Vander Vort John
Insider CIK 1379218 · CNAT 10% owner · PCRX · RDUS 10% owner · PETX Director, 10% owner · VSTM · EPZM 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 10,000 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 10,000 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 13,237 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 7,500 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 7,500 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 7,500 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 7,500 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer | 2019-07-18 | 2019-07-18 | 43,000 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2019-06-06 | 2019-06-07 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award | 2019-06-06 | 2019-06-07 | 4,500 | — | $0 | 43,000 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2018-07-27 | 2018-07-30 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award | 2018-07-27 | 2018-07-30 | 4,500 | — | $0 | 38,500 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2017-06-21 | 2017-06-23 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award | 2017-06-21 | 2017-06-23 | 4,500 | — | $0 | 34,000 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2016-06-24 | 2016-06-28 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award | 2016-06-24 | 2016-06-28 | 4,500 | — | $0 | 29,500 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2015-06-18 | 2015-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | S Sale | 2015-03-06 | 2015-03-06 | 6,137 | $20.01 | $122.8K | 25,000 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2014-06-19 | 2014-06-23 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion deriv | 2013-07-30 | 2013-08-01 | 265,837 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion deriv | 2013-07-30 | 2013-08-01 | 32,220 | — | $0 | 32,220 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion deriv | 2013-07-30 | 2013-08-01 | 8,333,334 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | J Other | 2013-07-30 | 2013-08-01 | 16,716 | $11.00 | $183.9K | 1,026,815 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | P Buy | 2013-07-30 | 2013-08-01 | 165,265 | $11.00 | $1.82M | 1,192,080 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion | 2013-07-30 | 2013-08-01 | 1,010,099 | — | $0 | 1,010,099 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | C Conversion deriv | 2013-07-02 | 2013-07-02 | 4,000,000 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | C Conversion deriv | 2013-07-02 | 2013-07-02 | 375,000 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | C Conversion deriv | 2013-07-02 | 2013-07-02 | 1,333,333 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | C Conversion | 2013-07-02 | 2013-07-02 | 802,246 | — | $0 | 3,625,419 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | C Conversion | 2013-07-02 | 2013-07-02 | 225,631 | — | $0 | 3,851,050 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | P Buy | 2013-07-02 | 2013-07-02 | 500,000 | $6.00 | $3.00M | 4,351,050 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | C Conversion | 2013-07-02 | 2013-07-02 | 2,406,739 | — | $0 | 2,823,173 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2013-06-26 | 2016-06-28 | 13,237 | — | $0 | 13,237 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion deriv | 2013-06-05 | 2013-06-06 | 1,176,472 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion deriv | 2013-06-05 | 2013-06-06 | 6,930,000 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion | 2013-06-05 | 2013-06-06 | 2,309,998 | — | $0 | 2,488,329 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion | 2013-06-05 | 2013-06-06 | 392,156 | — | $0 | 2,880,485 | SEC↗ |
| RDUS Radius Health, Inc. | P Buy deriv | 2013-04-23 | 2013-04-30 | 179,095 | $6.14 | $1.10M | 179,095 | SEC↗ |
| RDUS Radius Health, Inc. | P Buy deriv | 2013-04-23 | 2013-04-30 | 71,638 | $61.42 | $4.40M | 71,638 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-11 | 2013-03-13 | 500,000 | $27.86 | $13.93M | 2,790,479 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion deriv | 2012-02-01 | 2012-02-03 | 266,666 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion deriv | 2012-02-01 | 2012-02-03 | 2,500,000 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion deriv | 2012-02-01 | 2012-02-03 | 4,000,000 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | C Conversion | 2012-02-01 | 2012-02-03 | 1,933,333 | — | $0 | 1,933,333 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2012-02-01 | 2012-02-03 | 100,000 | $10.00 | $1.00M | 2,033,333 | SEC↗ |